NCT02103127已完成不适用
Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Severity Change in Acne Scarring
研究概览
简要总结
The purpose of this study is to assess treatment of facial acne scars using the 755nm Alexandrite Laser with lens arrays.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Is a healthy male or female between 18 and 65 years old
- •Has unwanted acne scars, excluding ice pick scars (Deep atrophic scars that resemble poked holes), and wishes to undergo laser treatments.
- •Is willing to consent to participate in the study.
- •Is willing to comply with all requirements of the study including biopsies, being photographed, following post treatment care and attending all treatment and follow up visits.
排除标准
- •The subject is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
- •The subject is hypersensitive to light exposure OR takes photo sensitized medication.
- •The subject has active or localized systemic infections.
- •The subject has a coagulation disorder or is currently using anti-coagulation medication (including but not limited to heavy aspirin therapy {greater than 81 mg per day}).
- •The subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
- •The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 3 months prior to entering this study.
- •The subject has used Accutane within 6 months prior to enrollment.
- •The subject has the need to be exposed to artificial tanning devices or excessive sunlight during the trial.
- •The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate).
- •The subject has a history of keloids.
- •The subject has evidence of compromised wound healing.
- •The subject has a history of squamous cell carcinoma or melanoma.
- •The subject has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications.
- •The subject has an allergy to lidocaine and epinephrine.
结局指标
主要结局
Severity Change in Acne Scarring
时间窗: Baseline and 3 months post treatment
The scale is a Physician Global Scarring Grading Scale, which counts and types scars by tallying up of the number and severity according to an organized grading system, where 0 is the lowest point value and represents no scarring. The theoretical highest score possible is an 84. The change in the score from the baseline to the follow up was collected. A negative change indicates a decrease in points (which indicates improvement).
次要结局
- Subject Satisfaction Questionnaire(3 months post treatment)
- Investigator Satisfaction Questionnaire(3 months post treatment)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Evaluation of the 755nm Alexandrite Laser for the Treatment of ScarsScarsNCT01811030Cynosure, Inc.33
已完成
不适用
Clinical and Histological Evaluation of the 755nm Alexandrite Laser With Handpiece for the Treatment of ScarsScarsNCT01813786Cynosure, Inc.9
已完成
不适用
Evaluation of the 755nm Alexandrite Laser for Skin Toning and Epidermal Pigmented Lesions in Asian Skin TypesEpidermal Pigmented LesionsSkin ToningNCT01754246Cynosure, Inc.20
已完成
不适用
Evaluation of the 755nm Alexandrite Laser for the Treatment of TattoosTattoosNCT01754207Cynosure, Inc.20
已完成
不适用
Evaluation of the 755nm Alexandrite for the Treatment of Epidermal and Dermal Pigmented LesionsDermal and Epidermal Pigmented LesionsNCT01754233Cynosure, Inc.6